ABOS vs NAMI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

ABOS

58.6
AI Score
VS
ABOS Wins

NAMI

35.4
AI Score

Investment Advisor Scores

ABOS

59score
Recommendation
HOLD

NAMI

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABOS NAMI Winner
Net Income -53.45M -13.49M NAMI
Operating Income -53.70M -14.91M NAMI
ROE -93.3% -112.5% ABOS
ROA -46.1% -49.1% ABOS
Total Assets 116.01M 27.49M ABOS
Cash 59.44M 9.19M ABOS
Current Ratio 2.47 1.53 ABOS

Relative Price Performance (Last 90 Days)

ABOS 1M: -33.2% · 3M: -20.6% NAMI 1M: -6.6% · 3M: -42.5%

Current Technical Phase

ABOS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 31

RSI (14): 31.4 · Price: $1.77

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

Fundamentals Snapshot

Metric ABOS NAMI
Market Cap — —
Forward P/E -1.2 0.0
Trailing P/E — 0.9
Revenue (TTM) — —
Revenue Growth 0.0% -0.3%
Gross Margin -263.8% 0.1%
Operating Margin 0.0% -0.1%
EPS -1.64 1.93
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABOS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.